Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 28

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Effect of Hydrogel Persistence on Pharmacodynamics and Tolerability of OTX-TIC, Travoprost Intracameral Implant in Beagles

Jennifer Langh; Charles D Blizzard; Arthur Driscoll; Ankita Desai; Noah Buff; Celia Johnston; Jeremy Hartman; Jessica Mangano; Nicholas Bova; Srilatha Vantipalli; Jamie Lynne Metzinger; Michael H Goldstein

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1242. doi:

ARVO Annual Meeting Abstract June 2020

Evaluating Safety and Pharmacokinetics of OTX-CSI, a Sustained Release Intracanalicular Cyclosporine Insert in Beagles

Andrew Vanslette; Paul Haberman; Charles D Blizzard; Arthur Driscoll; Srilatha Vantipalli; Jamie Lynne Metzinger; Michael H Goldstein

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3258. doi:

ARVO Annual Meeting Abstract June 2020

Evaluating Tolerability and Pharmacokinetics of OTX-BDI, a Sustained-Release Intracanalicular Insert Co-Delivering Besifloxacin & Dexamethasone in Beagles

Courtney Rosales; Charles D Blizzard; Tyler Peters; Luke Rausch; Arthur Driscoll; Srilatha Vantipalli; Jamie Lynne Metzinger; Michael H Goldstein

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):426. doi:

ARVO Annual Meeting Abstract July 2019

Pharmacodynamic Effect and Corneal Wound Healing of OTX-BPI, a Sustained Release Bupivacaine Intracanalicular Hydrogel Insert in Beagle Dogs

Rami F Elhayek; Jacob Dexter; Nelson Bello; Erica Kahn; Stephanie Manning; Charles D Blizzard; Arthur Driscoll; Jamie L Metzinger; Michael H Goldstein; Peter K Jarrett

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2099. doi:

ARVO Annual Meeting Abstract July 2019

Pharmacokinetics of OTX-CSI, a Sustained Release Cyclosporine Intracanalicular Insert in Beagles

Andrew Vanslette; Charles D Blizzard; Paul Haberman; Julia Tomaszewski; Courtney Rosales; Jamie L Metzinger; Michael H Goldstein; Arthur Driscoll

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):285. doi:

ARVO Annual Meeting Abstract July 2019

Effect of OTX-TIC, a Sustained Release Travoprost Intracameral Implant on Central Corneal Thickness in Beagles

Arthur Driscoll; Charles D Blizzard; Ankita Desai; Jennifer Langh; Noah Buff; Jamie L Metzinger; Michael H Goldstein; Ann Gelormini

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3345. doi:

ARVO Annual Meeting Abstract July 2019

Pharmacokinetics of OTX-TIC, a Sustained Release Travoprost Intracameral Implant in Rabbits

Charles D Blizzard; Ankita Desai; Jennifer Langh; Noah Buff; Jamie L Metzinger; Michael H Goldstein; Ann Gelormini; Arthur Driscoll

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3777. doi:

ARVO Annual Meeting Abstract July 2018

Safety Analysis of a Sustained Release Travoprost Intracameral Hydrogel Implant in Beagle Dogs

Arthur Driscoll; Charles D Blizzard; Ankita Desai; Shelby D'Abbraccio; Jennifer Langh; Jessica Mangano; Noah Buff; Jamie Lynne Metzinger; Michael H Goldstein; Ann Gelormini

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1250. doi:

ARVO Annual Meeting Abstract July 2018

Efficacy and Pharmacokinetics of a Sustained Release Travoprost Intracameral Hydrogel Implant in Beagle Dogs

Charles D Blizzard; Ankita Desai; Shelby D'Abbraccio; Jessica Mangano; Jennifer Langh; Noah Buff; Jamie Lynne Metzinger; Michael H Goldstein; Ann Gelormini; Arthur Driscoll

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1245. doi:

ARVO Annual Meeting Abstract June 2017

Tolerability of a Shape Changing Intravitreal Hydrogel Depot

Arthur Driscoll; Charles D Blizzard; Jonathan H Talamo; Peter K Jarrett; Rami F Elhayek; Tim Jarrett; Zach Lattrell; Michael McGrath; Stephen Takach; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1980. doi:

ARVO Annual Meeting Abstract September 2016

Tolerability of In Situ Forming Intravitreal Hydrogel Depots for Anti-VEGF Sustained Release in a Rabbit Model

Charles D Blizzard; Courtney Rosales; Timothy Jarrett; Rami F Elhayek; sarah guedez; Andrew Vanslette; Peter K Jarrett; Arthur Driscoll; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1120. doi:

ARVO Annual Meeting Abstract September 2016

Treatment of Chronic Allergic Conjunctivitis with Sustained Release Dexamethasone Using a Modified Conjunctival Allergen Challenge (Ora-CAC®) Model

Deepa Mulani; Eugene B McLaurin; Carolyn Repke; Michelle Sato; Paul J Gomes; Eric Ankerud; Michael Bassett; Charles D Blizzard; Arthur Driscoll; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4021. doi:

ARVO Annual Meeting Abstract June 2015

A Toxicological Evaluation of a Single Dose, 90 Day Sustained Release Travoprost Punctum Plug in Canines

Arthur Driscoll; Charles D Blizzard; Ankita Desai; Taylor Dickman; Michael Bassett; Douglas Molla; William Cowe; Jennifer Wittbold; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1993. doi:

ARVO Annual Meeting Abstract June 2015

Influence of Storage Temperature on Sustained Release Dexamethasone Pharmacokinetics in a Beagle Model

Charles D Blizzard; Michael McGrath; Steve Takach; Monica O'Connor; Simone Charles; Douglas Molla; Jennifer Wittbold; William Cowe; Arthur Driscoll; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):237. doi:

ARVO Annual Meeting Abstract June 2015

Dose Based Pharmacokinetics of Sustained Release Dexamethasone in Beagles

Andrew Vanslette; Michael McGrath; Monica O'Connor; Charles D Blizzard; Ankita Desai; Michael Bassett; Peter K Jarrett; Arthur Driscoll; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):238. doi:

ARVO Annual Meeting Abstract June 2015

One-Year Stability of a Sustained Release Travoprost Biodegradable Hydrogel Punctum Plug for the Treatment of Glaucoma

Douglas Molla; Monica O'Connor; Charles D Blizzard; Michael Bassett; Ankita Desai; Steve Takach; William Cowe; Jennifer Wittbold; Arthur Driscoll; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5707. doi:

ARVO Annual Meeting Abstract June 2015

Evaluating Sustained Release Dexamethasone for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge (Ora-CAC®) Model

Michael Bassett; Deepa Mulani; Charles D Blizzard; Arthur Driscoll; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4894. doi:

ARVO Annual Meeting Abstract June 2015

Preservation of Bevacizumab Anti-VEGF Bioactivity and Monomeric Structure During Processing into a Sustained Release Bevacizumab Intravitreal Depot

sarah guedez; Charles D Blizzard; allison wyand; Jennifer Wittbold; Rami F Elhayek; Andrew Vanslette; Peter K Jarrett; Arthur Driscoll; Amar Sawhney

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1500. doi:

ARVO Annual Meeting Abstract June 2015

Pharmacokinetics of Bevacizumab Sustained Release from Intravitreal Hydrogel Depots in a Rabbit Model Compared to a single Avastin Dose

Rami F Elhayek; Peter K Jarrett; Amar Sawhney; Arthur Driscoll; Timothy S. Jarrett; Courtney Rosales; Andrew Vanslette; Charles D Blizzard; sarah guedez

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1522. doi:

ARVO Annual Meeting Abstract April 2014

In Vivo Drug Delivery of Low Solubility Drugs from Biodegradable Hydrogel Punctum Plugs

Michael McGrath; Charles D Blizzard; Ankita Desai; Michael Bassett; Peter Jarrett; Arthur Driscoll; Amarpreet Sawhney

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):472. doi:

1 2

Next 20 Results »

Advertisement